Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Conditions: Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm Interventions: Drug: Olanzapine; Drug: Placebo Administration; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Conditions: Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm Interventions: Drug: Olanzapine; Drug: Placebo Administration; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials